觀點復星

Fosun: sell the trophy assets first
Lex專欄:復星減持策略並不明智

Data suggest the highly indebted Chinese conglomerate is in a bad place
數據似乎顯示這家揹負沉重債務的中國企業集團處境不佳,但其實體減持核心醫療資產的計劃看起來像是一個錯誤。

Fosun is showing signs of stress. The highly indebted Chinese conglomerate has alarmed investors with one of its entities planning to cut its holding in a core healthcare unit. It has followed up by saying it will file a lawsuit against Bloomberg. The bone of contention was a news report alleging that regulators asked some lenders and state-owned companies to examine their exposure to Fosun.

復星(Fosun)顯示出承受壓力的跡象。這家揹負沉重債務的中國企業集團令投資者感到震驚,因爲其旗下實體之一計劃減持在一家核心醫療子公司所持股份。該集團隨後表示將對彭博(Bloomberg)提起訴訟。爭論焦點是一則新聞報導,該報導稱監管機構要求一些銀行和國有企業摸底各自對復星的敞口。

您已閱讀16%(535字),剩餘84%(2768字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×